Filters
Results 1 - 10 of 5171
Results 1 - 10 of 5171.
Search took: 0.032 seconds
Sort by: date | relevance |
AbstractAbstract
No abstract available
Primary Subject
Source
International Atomic Energy Agency, Vienna (Austria); Proceedings series; 2 v.; v. 1 p. 71-85; 1974; IAEA; Vienna; Symposium on radioimmunoassay and related procedures in clinical medicine and research; Istanbul, Turkey; 10 Sep 1973; IAEA-SM--177/205
Record Type
Book
Literature Type
Conference
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] A spectro fluorometric method was developed for determination of brassinosteroids plant hormones based on the reaction between brassinolide and m-dansylaminophenylboronic acid. 90 μM of m-dansylaminophenylboronic acid solution was chosen as the optimal concentration of the reagent. The temperature of the reaction was 30 degree Celsius (room temperature) for 20 min duration in 5 mM phosphate buffer solution, pH 7. The excitation and emission wavelengths were 380 nm and 505 nm, respectively. Under optimal condition, linearity was found in the range 1-50 μM. Standard addition was used for the brassinosteroids determination in bio-extract samples, without any sample preparation. Limit of detection (3SD, n=10) of 0.24 μM and limit of quantitation (10SD, n=10) of 0.48 μM were obtained using sample blank with this standard addition method. Result was demonstrated to be a suitable semi-quantitative technique and was applied successfully for the determination of total brassinosteroids plant hormones equivalent to brassinolide. (author)
Primary Subject
Source
Abstract and full text available in http://pkukmweb.ukm.my/mjas/; Official journal of The Malaysian Analytical Sciences Society (ANALIS)
Record Type
Journal Article
Journal
Malaysian Journal of Analytical Sciences; ISSN 1394-2506;
; v. 19(3); p. 557-564

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Purpose: Hormonal stimulation can induce background enhancement (BE) in MR mammography (MRM). This fact has been assumed to decrease the accuracy of MRM. Consequently, this report investigates: 1. The prevalence of BE in postmenopausal vs. premenopausal women in correlation to hormonal cycle phase (CP). 2. The impact of hormonal status (HS) and BE on diagnostic accuracy. Materials and Methods: Consecutive patients over 22 months with complete HS information (week of CP or postmenopausal) were included in this prospective investigation. Exclusion criteria were any hormonal therapy, hysterectomy as well as cancer proven by biopsy. The standard of reference was histopathology. All MRM scans were acquired using the same protocol (1.5 T, dynamic T 1w GRE after 0.1 mmol/kg bw Gd-DTPA i. v.). Two radiologists rated all examinations in consensus according to BI-RADS. BE was defined as: 0 = missing, 1 = moderate, 2 = distinct. Results: 224 patients (150 postmenopausal, 74 premenopausal, 45 in the second week of CP) were included in this study (83 benign and 141 malignant findings). BE was more frequent in premenopausal women (p = 0.006), but did not differ between CP (p = 0.460). Neither HS nor BE had a significant impact on the diagnostic parameters of MRM (p ≥ 0.375). However, regarding BE, the relative number of false positive (FP) findings was highest (5 / 10; 50 %) in the distinct BE group. Regarding HS, 17 % more FP findings were observed in premenopausal women examined outside the second week of CP. Conclusion: In premenopausal women, HS leads to increased BE of breast tissue, independent of CP. Distinct BE and less pronounced, non-optimal CP may lead to an increased number of false positive findings. (orig.)
Primary Subject
Record Type
Journal Article
Journal
RoeFo - Fortschritte auf dem Gebiete der Roentgenstrahlen und der bildgebenden Verfahren; ISSN 1438-9029;
; CODEN RFGNDO; v. 183(5); p. 441-447

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Short note
Original Title
Informativnost' nekotorykh pokazatelej gormonal'nogo statusa v differentsial'noj diagnostike raka, tuberkuleza i khronicheskikh nespetsificheskikh zabolevanij
Primary Subject
Source
Akademiya Meditsinskikh Nauk SSSR, Tomsk (USSR). Onkologicheskij Nauchnyj Tsentr; 124 p; 1989; p. 70-71; Republican conference on actual problems in clinical oncology; Tomsk (USSR); 17 Oct 1989
Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Short note
Original Title
Gormony tireoidnogo profilya u bol'nykh rakom shchitovidnoj zhelezy v ehndemichnoj zone
Primary Subject
Source
12. All-union conference of roentgenologists and radiologists; Leningrad (USSR); 15-17 Nov 1990
Record Type
Journal Article
Literature Type
Conference
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
No abstract available
Primary Subject
Source
International Atomic Energy Agency, Vienna (Austria); Proceedings series; 825 p; ISBN 92-0-010482-7;
; 1982; p. 537-540; IAEA; Vienna; International symposium on radioimmunoassay and related procedures in medicine; Vienna (Austria); 21-25 Jun 1982; IAEA-SM--259/78P; Short communication only.

Record Type
Book
Literature Type
Conference
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] This is an analysis of 39 patients studied at the Yonsei Medical Center from January, 1976 to March 1979. Of these 35 patient were suspected of having hypothalamic insufficiency and subjected to the L-Dopa stimulation test to observe growth hormone secretary function while four acromegaly patient received the glucose loading test and L-Dopa stimulation test. The results are as follows: 1) The basal level of GH in the various disease was as follows: a) The basal level was lower than the control level but was not statistically significant b) In diabetes the mean value tended to higher than the control level but was not significant statistically c) In all four acromegaly patients the GH level was significantly higher than the control level 2) Of 13 patients with diabetes, nine had diabetic retinopathy, and of those nine, six showed increased L-Dopa response. However, of the four non retinopathic DM patients, only one showed increased response to L-Dopa. 3) Two patients out of ten with Sheehan's syndrome responded to L-Dopa stimulation. 4) One Patient of eight with pituitary chromophobe adenoma responded to L-Dopa stimulation. 5) Four acromegaly patients revealed 3 acidophilic adenoma and one chromophobe adenoma histologically. Of patients receiving the L-Dopa stimulation test. Two showed a paradoxical response. Two patients who received the glucose loading test showed suppressed response. 6) Of two craniopharyngioma patients, one showed increased GH response after L-Dopa stimulation. Increased response of GH after L-Dopa stimulation was seen in one two craniopharyngioma patients and also in one of two patients with short structure.
Primary Subject
Source
15 refs, 1 fig, 6 tabs
Record Type
Journal Article
Journal
Korean Journal of Nuclear Medicine; ISSN 1225-6714;
; v. 13(1); p. 37-43

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Afroz, S; Nasreen, F; Hossain, S; Begum, R; Taslima, BDA
Society of Nuclear Medicine, Bangladesh (Bangladesh)2001
Society of Nuclear Medicine, Bangladesh (Bangladesh)2001
AbstractAbstract
[en] Hypothyroidism is a common and well treatable disease. Regular follow up and good compliance of the patients are the main key features for a successful outcome. In our country, most of the patients come from a poor socio-economic background and are referred to the Nuclear Medicine Centre for thyroid function tests. As the referral is from either Surgeons, ENT specialists or general physicians and the cost for repeated investigations are quite expensive, the patients gradually lose interest in regular follow-ups. In addition, they do not take thyroxine regularly and the ultimate fate is disappointing. Realizing these problems we decided to threat those patients in our centre and offer them a nominal charge for the hormonal estimations and follow up managements. A total number of 174 patients were studied in 5 years (1997-2001). Out of 174 patients 48 patients were toxic patients receiving radioiodine and the rest 126 were hypothyroid due to other causes. 72.41% patients had regular follow up and amongst them, 57.14% became euthyroid. The test were improving. (author) 11 refs., 2 tabs
Primary Subject
Source
11 refs., 2 tabs.
Record Type
Journal Article
Journal
Bangladesh Journal of Nuclear Medicine; ISSN 1562-3831;
; v. 4(1); p. 29-31

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Hamza, G.R.A.
Faculty of Scienc, Ain Shams University, Cairo (Egypt)2015
Faculty of Scienc, Ain Shams University, Cairo (Egypt)2015
AbstractAbstract
[en] Dehydroepiandrosterone Sulfate (DHEAS) is an adrenal hormone, and is the most abundant circulatory steroid hormone in the body. Serum DHEAS concentration peaks at around age 25 years, displaying a significant decrease with age linked with some pathological changes. Objective: This study was performed to investigate the effect(s) of DHEAS oral administration, and its possible prophylactic and/or mitigating roles against γ-irradiation-induced disorders in the irradiated rat. Experimental Animals and Design: Five groups of male Albino rats were used: 1- Control: untreated group. 2- Irradiated: animals exposed to a single dose of whole-body γ-irradiation (6 Gy). 3- DHEAS group: given a single dose of DHEAS (20 mg/100 g b. wt.), intra gastrically. 4-DHEAS + Irrad. group: given a single dose of DHEAS, 2 hrs before irradiation. 5- Irrad.+ DHEAS group: given DHEAS, 2 hrs after irradiation. Blood and testicular tissue samples were collected after one day, one week and two weeks post irradiation or DHEAS treatment. Parameters Measured: Plasma levels of triiodothyronine (T3), thyroxin (T4), thyrotropin (TSH), testosterone, acid phosphatase (ACP), triglycerides (TG), total cholesterol, high density lipoprotein-cholesterol (HDL-Ch), low density lipoprotein-cholesterol (LDL-Ch) were determined, and the atherogenic index (AI) was calculated. Reduced glutathione (GSH) content and malondialdehyde (MDA) levels were measured in blood and testes. A complete blood picture and some biophysical properties were also examined. Results: DHEAS administration pre-irradiation, and to a lesser magnitude, post-irradiation, improved the disturbances induced by irradiation in the plasma levels of the tested parameters: tT3, tT4, and TSH, testosterone and the lipid profile, showing almost normalization of the AI. Beneficial effects were also observed in the hematological picture, blood viscosity and conductivity. DHEAS elevated GSH levels and decreased lipid peroxidation (LPO) in blood and testicular tissues. Conclusion: DHEAS exerts clear antioxidant and antiatherogenic effects, which were more prominent when administered before exposure to radiation than after. This prophylactic effect was brought about by protecting the cellular vital components from ROS generated by gamma radiation
Primary Subject
Source
2015; 190 p; Available from ILO of Egypt; 24 tabs., 28 figs., 210 refs.; Theses (Ph.D.)
Record Type
Miscellaneous
Literature Type
Thesis/Dissertation
Report Number
Country of publication
ANDROGENS, ANDROSTANES, ANIMALS, DRUGS, ELECTROMAGNETIC RADIATION, HORMONES, HYDROXY COMPOUNDS, IONIZING RADIATIONS, KETONES, MAMMALS, ORGANIC COMPOUNDS, PEPTIDE HORMONES, PEPTIDES, POLYPEPTIDES, PROTEINS, RADIATIONS, RADIOPROTECTIVE SUBSTANCES, RESPONSE MODIFYING FACTORS, RODENTS, STEROID HORMONES, STEROIDS, THYROID HORMONES, VERTEBRATES
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Peptide YY hormone (PYY) was recently appreciated as an important gut hormonal regulator of appetite. PYY is produced by the gut and released into the circulation after food intake and is found to decrease appetite. The main form of PYY, both stored and circulated, is PYY(3-36), the N-terminal truncated form of the full length peptide so, peripheral injections of PYY(3-36) in rats inhibit food intake in experimental animals as well as in lean and obese human subjects. Also, this hormone has been suggested to be an attractive therapeutic option for obesity. PYY levels are influenced by age and the highest hormone level is achieved in early postnatal life (day 30) and is decreased thereafter. PYY levels were also dependent on thyroid hormone status and being decreased in hyperthyroid rats. The PYY levels observed in acute and chronic food restricted rats indicated that, in situations of decreased energy intake, the lower PYY levels could serve to regulate central pathways and facilitate food intake. Contrary, in pregnant rats, PYY levels were enhanced at late gestation. The aim of this study was to assess the influence of age, sex, thyroid status, pregnancy and food restriction on PYY levels in rats. The underling mechanisms through which PYY levels alternated as a result of sex, age, pregnancy, thyroidal and nutritional status were discussed in the light of recent research outcomes
Primary Subject
Record Type
Journal Article
Journal
Isotope and Radiation Research; ISSN 0021-1907;
; v. 38(3); p. 615-629

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
1 | 2 | 3 | Next |